- Home
- / Century Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Century Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.4
2024-10-29
Market Capitalization
$115.2 M
2024-10-29
Revenue
$109.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 5.2M | 2.2M | 6.6M | 109.2M | |
| General and administrative expense | 19.2M | 31.9M | 34.7M | 33.2M | 24.0M |
| Operating expense total | 129.0M | 140.4M | 119.7M | ||
| EBIT | (94.9M) | (133.8M) | (146.5M) | (138.1M) | (17.3M) |
| EBIT margin, % | -2574.2% | -2096.5% | -15.8% | ||
| Interest income | 377.0K | 13.0M | 7.3M | ||
| Interest expense | 1.3M | 540.0K | |||
| Pre tax profit | (95.8M) | (130.8M) | (134.8M) | (124.8M) | (9.6M) |
| Income tax expense | 43.0K | 91.0K | 1.9M | 1.8M | (68.0K) |
| Net Income | (95.8M) | (130.9M) | (136.7M) | (126.6M) | (9.6M) |
| EPS | (2.3) | (2.0) | (1.6) | (0.1) |